ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,530,000 | -53.4% | 366,780 | -45.1% | 0.42% | -53.8% |
| Q4 2017 | $9,724,000 | +50.8% | 668,320 | +47.5% | 0.91% | +46.1% |
| Q3 2017 | $6,447,000 | +203.2% | 453,080 | +185.9% | 0.62% | +11.1% |
| Q3 2014 | $2,126,000 | -25.6% | 158,450 | -11.0% | 0.56% | -25.1% |
| Q2 2014 | $2,856,000 | +11.5% | 177,938 | +25.2% | 0.75% | -19.8% |
| Q1 2014 | $2,562,000 | – | 142,100 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |